NCT04494048Recruiting
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 9999 (estimated)
- First submitted
- 13 May 2020
- Start date
- 5 Apr 2016
- Primary completion date
- 31 Oct 2035
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Obesity
- NCT number
- NCT04494048
What you commit to
- Study type: Observational
- Planned participants: 9999
- From 5 Apr 2016 to the primary completion date, 31 Oct 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Below 18 years of age.
Other
- Any patient who has not undergone or will undergo EBT for weight loss
Who the study is looking for
- Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
- Above or equal to 18 years of age.
Age in the registry: 18 years to 89 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medicine Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.